Stéphanie Cornen

2.0k total citations · 2 hit papers
10 papers, 1000 citations indexed

About

Stéphanie Cornen is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Stéphanie Cornen has authored 10 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Stéphanie Cornen's work include Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (2 papers). Stéphanie Cornen is often cited by papers focused on Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (2 papers). Stéphanie Cornen collaborates with scholars based in France, United States and Algeria. Stéphanie Cornen's co-authors include Éric Vivier, Yannis Morel, Olivier Demaria, Marc Daëron, Ruslan Medzhitov, Valeria R. Fantin, Émilie Narni-Mancinelli, A Letessier, Patrice Viens and Nadine Carbuccia and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Stéphanie Cornen

10 papers receiving 986 citations

Hit Papers

Harnessing innate immunity in cancer therapy 2019 2026 2021 2023 2019 2024 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphanie Cornen France 6 655 419 333 186 102 10 1000
Paulina Pathria United States 5 625 1.0× 378 0.9× 361 1.1× 129 0.7× 146 1.4× 5 992
Marion V. Guérin France 9 699 1.1× 601 1.4× 269 0.8× 123 0.7× 91 0.9× 10 1.0k
Matthew Lin United States 6 524 0.8× 387 0.9× 340 1.0× 288 1.5× 46 0.5× 10 899
Tiani L. Louis United States 4 721 1.1× 395 0.9× 357 1.1× 124 0.7× 141 1.4× 4 1.1k
Greg Motz United States 5 653 1.0× 590 1.4× 232 0.7× 109 0.6× 70 0.7× 10 947
Dandan Wan China 11 440 0.7× 291 0.7× 360 1.1× 235 1.3× 64 0.6× 16 919
Jeremiah L. Oyer United States 15 449 0.7× 406 1.0× 289 0.9× 149 0.8× 41 0.4× 33 914
Sabina Kaczanowska United States 8 524 0.8× 361 0.9× 319 1.0× 72 0.4× 136 1.3× 11 870
Chuanhui Han United States 15 613 0.9× 399 1.0× 463 1.4× 186 1.0× 78 0.8× 29 1.1k
Amani Makkouk United States 11 445 0.7× 357 0.9× 242 0.7× 259 1.4× 36 0.4× 20 839

Countries citing papers authored by Stéphanie Cornen

Since Specialization
Citations

This map shows the geographic impact of Stéphanie Cornen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Cornen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Cornen more than expected).

Fields of papers citing papers by Stéphanie Cornen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Cornen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Cornen. The network helps show where Stéphanie Cornen may publish in the future.

Co-authorship network of co-authors of Stéphanie Cornen

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Cornen. A scholar is included among the top collaborators of Stéphanie Cornen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Cornen. Stéphanie Cornen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Vivier, Éric, et al.. (2024). Natural killer cell therapies. Nature. 626(8000). 727–736. 208 indexed citations breakdown →
2.
Colevas, Dimitrios, Krzysztof Misiukiewicz, Alexander T. Pearson, et al.. (2021). 123MO Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial. Annals of Oncology. 32. S1432–S1432. 12 indexed citations
3.
Demaria, Olivier, Éric Vivier, Marie Vétizou, et al.. (2021). 851 Harnessing innate immunity in cancer therapies: the example of natural killer cell engagers. Regular and Young Investigator Award Abstracts. A892–A892. 5 indexed citations
5.
Demaria, Olivier, Stéphanie Cornen, Marc Daëron, et al.. (2019). Harnessing innate immunity in cancer therapy. Nature. 574(7776). 45–56. 702 indexed citations breakdown →
6.
Roy, Aude Le, Caroline Soulas, Benjamín Rossi, et al.. (2018). Abstract 2713: Preclinical development of first-in-class antibodies targeting Siglec-9 immune checkpoint for cancer immunotherapy. Cancer Research. 78(13_Supplement). 2713–2713. 10 indexed citations
7.
Cornen, Stéphanie, Arnaud Guillé, José Adélaı̈de, et al.. (2014). Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling. PLoS ONE. 9(1). e81843–e81843. 53 indexed citations
8.
Bléry, Mathieu, Cécile Bonnafous, Valentine Péri, et al.. (2014). Abstract 5037: Targeting MICA with therapeutic antibodies for the treatment of cancer. Cancer Research. 74(19_Supplement). 5037–5037. 1 indexed citations
9.
Bonnafous, Cécile, Valentine Péri, Sylvia Trichard, et al.. (2013). Targeting MICA with therapeutic antibodies for the treatment of cancer. Journal for ImmunoTherapy of Cancer. 1(Suppl 1). P41–P41. 4 indexed citations
10.
Chaffanet, Max, José Adélaı̈de, Stéphanie Cornen, et al.. (2012). Integrated Genomic Analysis of Breast Cancers. SHILAP Revista de lepidopterología. 15(Supplement). 71–74. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026